KRAS and colorectal carcinoma: The uncontrolled activation of KRAS is a hallmark event in CRC development, progression and metastasis, able to trigger multiple downstream pathways, including the RAF/MEK/ERK MAPK cascades, involved in intestinal tumorigenesis [52].